moxifloxacin has been researched along with ajmaline in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (ajmaline) | Trials (ajmaline) | Recent Studies (post-2010) (ajmaline) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 9 | 0 | 4 |
| Protein | Taxonomy | moxifloxacin (IC50) | ajmaline (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 1 | |
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 7 subunit alpha | Homo sapiens (human) | 8.2 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.04 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 11 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 8 subunit alpha | Homo sapiens (human) | 8.2 | |
| Sodium channel protein type 10 subunit alpha | Homo sapiens (human) | 8.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
2 other study(ies) available for moxifloxacin and ajmaline
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |